Table 7.
Factors | Y1 (nm) | Y2 (mV) | Y3 (%) | Y4 | ||||
---|---|---|---|---|---|---|---|---|
Coefficient | p-Value | Coefficient | p-Value | Coefficient | p-Value | Coefficient | p-Value | |
α0 | 483.41 | 0.0269 | −12.86 | 0.0279 | 63.93 | 0.0200 | 0.47 | 0.0469 |
X1 | −16.59 | 0.2563 | 0.43 | 0.1323 | −4.51 | 0.0098 | 0.052 | 0.4253 |
X2 | 45.53 | 0.0499 | −0.077 | 0.5508 | 3.02 | 0.0214 | −0.071 | 0.2875 |
X3 | −81.08 | 0.0165 | −3.01 | 0.0190 | −5.33 | 0.0070 | −0.28 | 0.0082 |
X4 | 96.76 | 0.0117 | 6.93 | 0.0083 | −2.26 | 0.0373 | −0.20 | 0.0264 |
X5 | −73.76 | 0.0198 | −2.16 | 0.0265 | −1.95 | 0.0491 | e | e |
X6 | 96.59 | 0.0117 | −0.18 | 0.3000 | e | e | −0.088 | 0.2064 |
X7 | 39.91 | 0.0633 | −0.68 | 0.0842 | 1.50 | 0.0794 | −0.097 | 0.1719 |
X8 | e | e | 0.51 | 0.1112 | −1.30 | 0.1021 | 0.069 | 0.2987 |
Y1—average particle size; Y2—Zeta-potential; Y3—encapsulation efficiency; Y4—polydispersity index; α0—constant; X1—docetaxel amount in organic phase (mg); X2—PLGA amount in organic phase (mg); X3—surfactant concentration in aqueous phase (%); X4—surfactant type; X5—size reduction process; X6—solvent type; X7—vortexing speed in emulsification step (rpm); X8—stirrer speed in hardening step (rpm); e—Factors were not modeled by software.